140 related articles for article (PubMed ID: 36926819)
1. Liquid Biopsy-Based Volatile Organic Compounds from Blood and Urine and Their Combined Data Sets for Highly Accurate Detection of Cancer.
Einoch Amor R; Levy J; Broza YY; Vangravs R; Rapoport S; Zhang M; Wu W; Leja M; Behar JA; Haick H
ACS Sens; 2023 Apr; 8(4):1450-1461. PubMed ID: 36926819
[TBL] [Abstract][Full Text] [Related]
2. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
3. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
4. Artificially Intelligent Nanoarray Detects Various Cancers by Liquid Biopsy of Volatile Markers.
Einoch Amor R; Zinger A; Broza YY; Schroeder A; Haick H
Adv Healthc Mater; 2022 Sep; 11(17):e2200356. PubMed ID: 35765713
[TBL] [Abstract][Full Text] [Related]
5. Blood, urine and semen Volatile Organic Compound (VOC) pattern analysis for assessing health environmental impact in highly polluted areas in Italy.
Longo V; Forleo A; Ferramosca A; Notari T; Pappalardo S; Siciliano P; Capone S; Montano L
Environ Pollut; 2021 Oct; 286():117410. PubMed ID: 34052646
[TBL] [Abstract][Full Text] [Related]
6. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
Phillips M; Bauer TL; Pass HI
J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
[TBL] [Abstract][Full Text] [Related]
7. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
8. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
9. Infrared cavity ring-down spectroscopy for detecting non-small cell lung cancer in exhaled breath.
Larracy R; Phinyomark A; Scheme E
J Breath Res; 2022 Mar; 16(2):. PubMed ID: 35294929
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
11. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
[TBL] [Abstract][Full Text] [Related]
12. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
13. Volatile fingerprints of cancer specific genetic mutations.
Peled N; Barash O; Tisch U; Ionescu R; Broza YY; Ilouze M; Mattei J; Bunn PA; Hirsch FR; Haick H
Nanomedicine; 2013 Aug; 9(6):758-66. PubMed ID: 23428987
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine.
Giró Benet J; Seo M; Khine M; Gumà Padró J; Pardo Martnez A; Kurdahi F
Sci Rep; 2022 Sep; 12(1):14873. PubMed ID: 36050339
[TBL] [Abstract][Full Text] [Related]
15. Sniffing fungi - phenotyping of volatile chemical diversity in Trichoderma species.
Guo Y; Jud W; Ghirardo A; Antritter F; Benz JP; Schnitzler JP; Rosenkranz M
New Phytol; 2020 Jul; 227(1):244-259. PubMed ID: 32155672
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive cancer detection using volatile biomarkers: Is urine superior to breath?
Becker R
Med Hypotheses; 2020 Oct; 143():110060. PubMed ID: 32683218
[TBL] [Abstract][Full Text] [Related]
17. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.
Janssens E; van Meerbeeck JP; Lamote K
Crit Rev Oncol Hematol; 2020 Sep; 153():103037. PubMed ID: 32771940
[TBL] [Abstract][Full Text] [Related]
18. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
[TBL] [Abstract][Full Text] [Related]
19. Evaluating polyvinylidene fluoride - carbon black composites as solid phase microextraction coatings for the detection of urinary volatile organic compounds by gas chromatography-mass spectrometry.
Woollam M; Grocki P; Schulz E; Siegel AP; Deiss F; Agarwal M
J Chromatogr A; 2022 Dec; 1685():463606. PubMed ID: 36370629
[TBL] [Abstract][Full Text] [Related]
20. Prediction of breast cancer risk with volatile biomarkers in breath.
Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
